0 Kommentare
0 Geteilt
6KB Ansichten
0 Bewertungen
Suche
Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften
-
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
Temasek and GIC acquire stake in Singapore-headquartered biotech specialist CRO NovotechNovotech, Singapore-headquartered full-service biotech specialist clinical research organization (CRO), announced that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also reinvest through its TPG Asia fund, Novotech said in a statement...0 Kommentare 0 Geteilt 6KB Ansichten 0 Bewertungen
-
Temasek’s ClavystBio, Lightstone Ventures back Allay Therapeutics’ $57.5M Series D financingAllay Therapeutics, a clinical-stage biotechnology company, announced last Thursday the completion of a $57.5 million Series D financing round with leading global investors. The firm said in a statement that Lightstone Ventures and Temasek-backed ClavystBio co-led the Series D financing with participation by existing investors NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures Healthcare,...0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen
-
Temasek-backed SeaTown invests $89M in healthcare firm AddVitaTemasek-based investment firm SeaTown Holdings International announced Wednesday its investment via SeaTown Private Capital Master Fund (SeaTown PCap Fund) in AddVita, a Singapore headquartered healthcare and life sciences distribution company. With a capital commitment of up to S$115 million ($89.09 million) from SeaTown PCap Fund, this investment positions AddVita as an enduring home for...0 Kommentare 0 Geteilt 4KB Ansichten 0 Bewertungen
Gesponsert